Schwartz J M, Paress P S, Ross J M, DiPillo F, Rizek R
J Clin Invest. 1972 Jun;51(6):1594-601. doi: 10.1172/JCI106957.
The electrophoretic mobility of erythrocyte NADH methemoglobin reductase in five hereditary methemoglobinemia patients from three Puerto Rican kindreds was 118% of normal at pH 8.6. The methemoglobin ferrocyanide reductase activity of the enzyme in erythrocyte hemolysates was 3.2-6.4% of normal. Electrophoresis of hemolysates prepared from the blood of patients from two different families at six pH values between 4.6 and 9.3 did not differentiate between the variant enzymes. Examination of the deficient enzymes extracted from the erythrocytes of one patient from each kindred revealed altered affinity for NADH and dichloroindophenol dye and decreased thermal stability. The quantitative similarity of the abnormal findings, together with the Puerto Rican origin of the kindreds, suggested that the cyanotic patients possessed the same abnormal enzyme and were thus homozygous for the same rare mutant gene. Consanguinity of the kindreds could not be established. The rates of decline of the normal and variant NADH methemoglobin reductase enzymes in vivo were measured in erythrocyte fractions of increasing cell age. The rate of decline of the variant enzyme was increased 20-fold by comparison with the normal enzyme. The methemoglobin percentage in erythrocyte fractions of increasing cell age correlated inversely with the activity of the variant. The variant enzyme averaged 37% of normal mean activity in young cells and 1% in old cells. The normal enzyme, on the other hand, lost only one-sixth of its activity as the cells aged, and the methemoglobin content in old normal cells did not rise. These observations support the hypothesis that the deficient activity and the heterogeneous pattern of methemoglobin accumulation in vivo arise principally from the accelerated inactivation of variant NADH methemoglobin reductase during the life-span of the red blood cell.
来自三个波多黎各家族的五名遗传性高铁血红蛋白血症患者红细胞NADH高铁血红蛋白还原酶在pH 8.6时的电泳迁移率为正常的118%。该酶在红细胞溶血产物中的高铁氰化血红蛋白还原酶活性为正常的3.2% - 6.4%。对来自两个不同家族患者血液制备的溶血产物在4.6至9.3之间的六个pH值下进行电泳,未能区分变异酶。对每个家族一名患者红细胞中提取的缺陷酶进行检测,发现其对NADH和二氯靛酚染料的亲和力改变,热稳定性降低。异常结果的定量相似性,以及家族的波多黎各血统,表明这些发绀患者拥有相同的异常酶,因此是同一罕见突变基因的纯合子。家族的近亲关系无法确定。在不同细胞年龄的红细胞组分中测量了正常和变异NADH高铁血红蛋白还原酶在体内的下降速率。与正常酶相比,变异酶的下降速率增加了20倍。不同细胞年龄的红细胞组分中高铁血红蛋白百分比与变异酶活性呈负相关。变异酶在年轻细胞中的平均活性为正常平均活性的37%,在衰老细胞中为1%。另一方面,正常酶随着细胞衰老仅丧失其六分之一的活性,衰老正常细胞中的高铁血红蛋白含量并未升高。这些观察结果支持了这样的假说,即体内高铁血红蛋白积累的活性缺陷和异质性模式主要源于变异NADH高铁血红蛋白还原酶在红细胞寿命期间的加速失活。